Cosmo Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 4/6
Cosmo Pharmaceuticals is a dividend paying company with a current yield of 2.96% that is well covered by earnings.
Key information
3.0%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 3.1% |
| Future Dividend Yield | 1.4% |
| Dividend Growth | 16.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €2.000 |
| Payout ratio | 46% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: C43's dividend payments have been volatile in the past 10 years.
Growing Dividend: C43's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Cosmo Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (C43) | 3.0% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.9% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (C43) (up to 3 years) | 1.4% |
Notable Dividend: C43's dividend (2.96%) is higher than the bottom 25% of dividend payers in the German market (1.73%).
High Dividend: C43's dividend (2.96%) is low compared to the top 25% of dividend payers in the German market (4.81%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (46.2%), C43's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (32.8%), C43's dividend payments are well covered by cash flows.